AU2001296865A1 - (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents - Google Patents
(5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agentsInfo
- Publication number
- AU2001296865A1 AU2001296865A1 AU2001296865A AU9686501A AU2001296865A1 AU 2001296865 A1 AU2001296865 A1 AU 2001296865A1 AU 2001296865 A AU2001296865 A AU 2001296865A AU 9686501 A AU9686501 A AU 9686501A AU 2001296865 A1 AU2001296865 A1 AU 2001296865A1
- Authority
- AU
- Australia
- Prior art keywords
- chlorobenzoyl
- hydroxy
- salts
- same
- active agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
Abstract
(5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid, salts thereof, and compositions containing the same for the delivery of active agents are provided. Methods of administration, treatment of disease and preparation are provided as well.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23033200P | 2000-09-06 | 2000-09-06 | |
US60230332 | 2000-09-06 | ||
US60/230,332 | 2000-09-06 | ||
US23723400P | 2000-10-02 | 2000-10-02 | |
US60/237,234 | 2000-10-02 | ||
US60237234 | 2000-10-02 | ||
PCT/US2001/041985 WO2002019969A2 (en) | 2000-09-06 | 2001-09-05 | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001296865A1 true AU2001296865A1 (en) | 2002-03-22 |
Family
ID=26924132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001296865A Abandoned AU2001296865A1 (en) | 2000-09-06 | 2001-09-05 | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents |
Country Status (6)
Country | Link |
---|---|
US (1) | US7495030B2 (en) |
EP (1) | EP1322595B1 (en) |
AT (1) | ATE396967T1 (en) |
AU (1) | AU2001296865A1 (en) |
DE (1) | DE60134245D1 (en) |
WO (1) | WO2002019969A2 (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL126318A (en) | 1996-03-29 | 2004-09-27 | Emisphere Tech Inc | Compounds and compositions for delivering active agents and some novel carrier compounds |
US6358504B1 (en) * | 1997-02-07 | 2002-03-19 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
SK1182003A3 (en) | 2000-06-29 | 2003-09-11 | Emisphere Tech Inc | Compounds and compositions for delivering active agents |
RU2309945C2 (en) * | 2001-03-01 | 2007-11-10 | Эмисфере Текнолоджиз, Инк. | Compositions for bisphosphonates delivery |
MXPA06001353A (en) | 2003-08-08 | 2006-05-04 | Abgenix Inc | Antibodies directed to parathyroid hormone (pth) and uses thereof. |
US7318925B2 (en) | 2003-08-08 | 2008-01-15 | Amgen Fremont, Inc. | Methods of use for antibodies against parathyroid hormone |
RU2006138703A (en) | 2004-05-06 | 2008-06-20 | Эмисфире Текнолоджис | SOLID MEDICINAL FORM OF HUMIDIFIED HEPARIN |
MXPA06013252A (en) | 2004-05-14 | 2007-02-28 | Emisphere Tech Inc | Compounds and compositions for delivering active agents. |
BRPI0510221A (en) | 2004-05-14 | 2007-10-23 | Emisphere Tech Inc | aryl ketone compound, composition, unit dosage form, use of the composition and method for preparing a composition |
AU2005244986B2 (en) | 2004-05-19 | 2011-01-27 | Emisphere Technologies, Inc. | Topical cromolyn formulations |
WO2005112937A1 (en) | 2004-05-19 | 2005-12-01 | Emisphere Technologies, Inc. | Acyclovir formulations |
US20100048454A1 (en) | 2004-08-03 | 2010-02-25 | Emisphere Technologies, Inc. | Antidiabetic oral insulin-biguanide combination |
GB0427603D0 (en) * | 2004-12-16 | 2005-01-19 | Novartis Ag | Organic compounds |
AU2005321803B2 (en) | 2004-12-29 | 2012-02-09 | Emisphere Technologies, Inc. | Pharmaceutical formulations of gallium salts |
US8110547B2 (en) | 2005-01-12 | 2012-02-07 | Emisphere Technologies, Inc. | Compositions for buccal delivery of parathyroid hormone |
WO2007011958A2 (en) | 2005-07-15 | 2007-01-25 | Emisphere Technologies, Inc. | Intraoral dosage forms of glucagon |
US8927015B2 (en) | 2006-04-12 | 2015-01-06 | Emisphere Technologies, Inc. | Formulations for delivering insulin |
US8771712B2 (en) | 2006-05-09 | 2014-07-08 | Emisphere Technologies, Inc. | Topical administration of acyclovir |
US9364502B2 (en) | 2006-06-28 | 2016-06-14 | Emisphere Technologies, Inc. | Gallium nitrate formulations |
CA2662853C (en) * | 2006-08-31 | 2016-07-26 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO2008112706A1 (en) | 2007-03-13 | 2008-09-18 | Nutrition 21, Inc. | Methods and compositions for the sustained release of chromium |
WO2009002867A2 (en) | 2007-06-26 | 2008-12-31 | Nutrition 21, Inc. | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement |
FR2941563B1 (en) | 2009-01-26 | 2011-02-11 | Commissariat Energie Atomique | SEALED BARRIER FOR MICROCOMPONENT AND METHOD FOR MANUFACTURING SUCH BARRIER. |
JP5985985B2 (en) | 2009-08-03 | 2016-09-06 | エミスフィアー テクノロジーズ インコーポレイテッドEmisphere Technologies,Inc. | Rapid-acting naproxen composition with reduced gastrointestinal effects |
MX344925B (en) | 2011-03-01 | 2017-01-11 | N21 Acquisition Holding Llc | Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders. |
SG11201501850VA (en) | 2012-09-21 | 2015-04-29 | Intensity Therapeutics Inc | Method of treating cancer |
US11865121B2 (en) | 2016-02-11 | 2024-01-09 | Nutrition21, LLC | Chromium containing compositions for improving health and fitness |
BR112022015170A2 (en) | 2020-03-12 | 2022-10-11 | Baxter Int | DAPTOMYCIN FORMULATIONS CONTAINING A COMBINATION OF SORBITOL AND MANNITOL |
CN113929762B (en) * | 2021-12-16 | 2022-04-26 | 清华大学 | 3-hydroxybutyrylated and/or 3-hydroxypentylglycolylated modified insulin and application thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5583020A (en) | 1992-11-24 | 1996-12-10 | Ribozyme Pharmaceuticals, Inc. | Permeability enhancers for negatively charged polynucleotides |
US5650386A (en) * | 1995-03-31 | 1997-07-22 | Emisphere Technologies, Inc. | Compositions for oral delivery of active agents |
US5773647A (en) * | 1997-02-07 | 1998-06-30 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
HUP0103188A2 (en) * | 1998-08-07 | 2001-12-28 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
SK1182003A3 (en) * | 2000-06-29 | 2003-09-11 | Emisphere Tech Inc | Compounds and compositions for delivering active agents |
-
2001
- 2001-09-05 WO PCT/US2001/041985 patent/WO2002019969A2/en active Application Filing
- 2001-09-05 US US10/363,726 patent/US7495030B2/en not_active Expired - Fee Related
- 2001-09-05 DE DE60134245T patent/DE60134245D1/en not_active Expired - Lifetime
- 2001-09-05 AT AT01977774T patent/ATE396967T1/en not_active IP Right Cessation
- 2001-09-05 EP EP01977774A patent/EP1322595B1/en not_active Expired - Lifetime
- 2001-09-05 AU AU2001296865A patent/AU2001296865A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040023847A1 (en) | 2004-02-05 |
EP1322595A4 (en) | 2005-03-23 |
WO2002019969A2 (en) | 2002-03-14 |
EP1322595B1 (en) | 2008-05-28 |
US7495030B2 (en) | 2009-02-24 |
EP1322595A2 (en) | 2003-07-02 |
DE60134245D1 (en) | 2008-07-10 |
WO2002019969A3 (en) | 2002-07-11 |
ATE396967T1 (en) | 2008-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001296865A1 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
NZ524138A (en) | Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents | |
AU2274201A (en) | Compounds and compositions for delivering active agents | |
HK1054918A1 (en) | Compounds and compositions for delivering active agents | |
MXPA01008611A (en) | Compounds and compositions for delivering active agents. | |
WO2000007979A3 (en) | Compounds and compositions for delivering active agents | |
IL195055A0 (en) | Phenoxy carboxylic acid compounds and compositions for delivering active agents | |
AU3492100A (en) | Oxadiazole compounds and compositions for delivering active agents | |
WO2002070438A3 (en) | Compositions for delivering bisphosphonates | |
BR0008590A (en) | Polymeric delivery agent, composition, unit dosage form, method for administering a biologically active agent to an animal requiring the agent, method for preparing a composition; it's composed | |
EP0993831A3 (en) | Compounds and compositions for delivering active agents | |
MXPA03007857A (en) | Compounds and compositions for delivering active agents. | |
WO2003045306A3 (en) | Phenoxy amine compounds and compositions for delivering active agents | |
WO2002015959A3 (en) | Compounds and compositions for delivering active agents | |
AU3850600A (en) | Dalda analogs and their use | |
UA86776C2 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
WO2001070184A3 (en) | A composition containing monoterpenes for topical oral administration | |
WO2005062874A3 (en) | Compounds and compositions for delivering active agents | |
EP1676832A3 (en) | Compounds and compositions for delivering active agents |